As of July 2025 DBV Technologies has a market cap of โฌ0.23 Billion. This makes DBV Technologies the world's 8077th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | โฌ0.23 B | 248.14% |
2024 | โฌ67.81 M | -61.41% |
2023 | โฌ0.17 B | -34.44% |
2022 | โฌ0.26 B | 59.53% |
2021 | โฌ0.16 B | -29.32% |
2020 | โฌ0.23 B | -74.25% |
2019 | โฌ0.92 B | 188.92% |
2018 | โฌ0.31 B | -69.31% |
2017 | โฌ1.04 B | -35.5% |
2016 | โฌ1.61 B | 0.39% |
2015 | โฌ1.60 B | 90.82% |
2014 | โฌ0.84 B |
On Jul 28th, 2025 the market cap of DBV Technologies was reported to be:
Name | Marketcap | Market cap differencediff. | Country |
---|---|---|---|
![]() Ionis Pharmaceuticals
IONS | โฌ5.65 B | 2,294.30% | ๐บ๐ธ USA |
![]() Flexion Therapeutics
FLXN | โฌ0.39 B | 67.69% | ๐บ๐ธ USA |
![]() Alnylam Pharmaceuticals
ALNY | โฌ36.53 B | 15,374.16% | ๐บ๐ธ USA |